Description | This product is an inhibitory antibody that binds to IAV H2N2 NA. The antibody inhibits the activity of all A/group 2 and group 1 NAs as well as B/Victoria/2/87 lineage NAs. |
Clonality | Monoclonal |
Host Species | Human |
Target Species | Influenzavirus A Subtype H2N2, Influenzavirus A Subtype H1N1, Influenzavirus A Subtype H3N2 |
Cross Reactivity | mAb 1G01 exhibited the most extensive binding activity, covering all group 1 NAs (N1, N4, N5, and N8) and group 2 NAs (N2, N3, N6, N7, and N9), as well as NAs from both lineages of influenza B virus. |
IC50 | 1.35 nM |
Isotype | Human IgG |
Expression Species | HEK293F or CHO |
Conjugation | None |
Purity | >95%, determined by SDS-PAGE and SEC-HPLC |
Endotoxin | <1 EU/mg |
Purification | Protein A purified |
Sterility | 0.2 μM filtered |
Formulation | PBS, pH 7.4 |
Preservation | No preservatives |
Stabilizer | No stabilizers |
Storage | Store at 4°C within a week. For longer storage, aliquot and store at -20°C. |
Application | ELISA; Inhib; FuncS |
Application Notes | The antibody inhibits the activity of all A/group 2 and group 1 NAs and B/Victoria/2/87 lineage NA. |
ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
WB | Western Blot Protocol |
FC | Flow Cytometry Protocol |
Target | IAV H2N2 NA |
Alternative Name | Influenza A virus Neuraminidase; Influenza A virus; Neuraminidase; NA; IAV; N2; H2N2; IAV H2N2; H1N1; H3N2; N1 |
Research Area | Microbiology |